Priser
Platform
Blog
Om os
Download
301246
Hubei Hongyuan Pharmaceutical Technology Co
Shenzhen Stock Exchange
0

Om

Hubei Hongyuan Pharmaceutical Co., Ltd. operates within the pharmaceutical industry, primarily engaged in the research, development, production, and sale of pharmaceutical products. Recognized for its contribution to healthcare, the company focuses on creating medications that target a range of therapeutic areas. By leveraging advanced biotechnology and adhering to rigorous quality standards, it aims to meet the growing demands for effective healthcare solutions. The company plays a significant role in China's pharmaceutical sector, contributing to both domestic markets and, potentially, international ones. It is part of a highly regulated industry where it must comply with regional health and safety guidelines. This company's operations and products support the broader healthcare infrastructure, aiding in improving both public health outcomes and access to medical treatments.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I HUBEI HONGYUAN PHARMACEUTICAL TECHNOLOGY CO MED ENDAVU: Køb Hubei Hongyuan Pharmaceutical Technology Co ($301246) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Hubei Hongyuan Pharmaceutical Technology Co, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

Ticker301246
Land
Kina
Antal medarbejdere2.169
Hjemmesidehbhypharm.com
SektorSundhed
IndustriLægemiddelproducenter - Specialitet og generisk

Udbytter

0,05CNH
'24
0,03CNH
'25
Ex-udbytte-dato25. jun. 2025
Udbytteafkast0,12%